Total Payments
$4,597
2024 Payments
$327.12
Companies
21
Transactions
239
Medicare Patients
109
Medicare Billing
$25,627
Payment Breakdown by Category
Food & Beverage$4,504 (98.0%)
Education$92.83 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,504 | 233 | 98.0% |
| Education | $92.83 | 6 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $2,089 | 108 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $520.25 | 28 | $0 (2022) |
| Alkermes, Inc. | $278.58 | 17 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $264.22 | 12 | $0 (2022) |
| ITI, Inc. | $254.82 | 15 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $217.17 | 13 | $0 (2022) |
| AbbVie Inc. | $192.41 | 10 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $157.66 | 10 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $126.24 | 1 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $108.06 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $327.12 | 3 | E.R. Squibb & Sons, L.L.C. ($126.24) |
| 2023 | $559.91 | 13 | Otsuka America Pharmaceutical, Inc. ($416.06) |
| 2022 | $902.53 | 50 | ITI, Inc. ($164.87) |
| 2021 | $440.96 | 18 | Otsuka America Pharmaceutical, Inc. ($168.71) |
| 2020 | $298.63 | 19 | Otsuka America Pharmaceutical, Inc. ($122.57) |
| 2019 | $638.09 | 52 | Otsuka America Pharmaceutical, Inc. ($388.04) |
| 2018 | $858.13 | 51 | Otsuka America Pharmaceutical, Inc. ($357.08) |
| 2017 | $571.31 | 33 | Otsuka America Pharmaceutical, Inc. ($421.25) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $79.07 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $126.24 | General |
| 04/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $121.17 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 04/04/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PSYCHIATRY | ||||||
| 02/21/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Central Nervous System | ||||||
| 02/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: PSYCHIATRY | ||||||
| 02/07/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: PSYCHIATRY | ||||||
| 02/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 12/07/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Central Nervous System | ||||||
| 11/27/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Central Nervous System | ||||||
| 11/10/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $24.89 | General |
| 11/03/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Neuroscience | ||||||
| 10/18/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 99 | $22,904 | $6,399 |
| 2022 | 1 | 21 | 154 | $31,020 | $11,057 |
| 2021 | 2 | 29 | 93 | $19,158 | $6,303 |
| 2020 | 1 | 43 | 64 | $8,388 | $1,868 |
Total Patients
109
Total Services
410
Medicare Billing
$25,627
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 99 | $22,904 | $6,399 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 154 | $31,020 | $11,057 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 80 | $17,392 | $6,037 | 34.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 13 | $1,766 | $266.68 | 15.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 43 | 64 | $8,388 | $1,868 | 22.3% |
About Dr. James Byrd, D.O
Dr. James Byrd, D.O is a Psychiatry healthcare provider based in Wentzville, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730191701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Byrd, D.O has received a total of $4,597 in payments from pharmaceutical and medical device companies, with $327.12 received in 2024. These payments were reported across 239 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,504).
As a Medicare-enrolled provider, Byrd has provided services to 109 Medicare beneficiaries, totaling 410 services with total Medicare billing of $25,627. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Child & Adolescent Psychiatry
- Location Wentzville, MO
- Active Since 08/11/2006
- Last Updated 10/23/2018
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1730191701
Products in Payments
- REXULTI (Drug) $1,090
- ABILIFY MAINTENA (Drug) $955.76
- LATUDA (Drug) $520.25
- INGREZZA (Drug) $264.22
- CAPLYTA (Drug) $254.82
- ARISTADA (Drug) $186.79
- INVEGA SUSTENNA (Drug) $177.42
- VRAYLAR (Drug) $160.37
- Fanapt (Drug) $137.70
- ABILIFY ASIMTUFII (Drug) $121.17
- AUSTEDO (Drug) $108.06
- Aristada 441 mg (Drug) $91.79
- Auvelity (Drug) $79.07
- TRINTELLIX (Drug) $32.73
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $28.33
- INVEGA TRINZA (Drug) $25.26
- Trintellix (Drug) $23.46
- HETLIOZ (Drug) $19.96
- SUBOXONE SUBLINGUAL FILM (Drug) $15.63
- XARELTO (Drug) $14.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Wentzville
Dr. Harmeeta Singh, M.d, M.D
Psychiatry — Payments: $16,286
Psychiatry $16,286
David Goldmeier, M.d, M.D
Psychiatry — Payments: $6,573
Psychiatry $6,573
Fernando Perez-Magnelli, Md, MD
Psychiatry — Payments: $2,539
Psychiatry $2,539
Dr. Almas Rahman, M.d, M.D
Psychiatry — Payments: $2,409
Psychiatry $2,409
Dr. Gopinath Gorthy, Md, MD
Psychiatry — Payments: $893.51
Psychiatry $893.51
Pappa Ehimare, Md, MD
Psychiatry — Payments: $844.20
Psychiatry $844.20